Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Treatment Trial
PACTR202102588777597Phase 3Unknown
- Sponsor
- Lagos State Ministry of Health
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin plus standard of care with Standard of care (2 arms). Primary endpoint: Mortality. Status: unknown.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202102588777597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102588777597.